Cargando…

Annexin A2 is not a good biomarker for hepatocellular carcinoma in cirrhosis

In China, hepatocellular carcinoma (HCC) usually develops following a long history of chronic hepatitis B infection or cirrhosis. To evaluate the diagnostic role of annexin A2 (ANXA2), a possible tumor marker, in patients with hepatitis B virus (HBV)-related HCC, particularly those with a history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	LIU, ZHIKUN, LING, QI, WANG, JIANGUO, XIE, HAIYANG, XU, XIAO, ZHENG, SHUSEN
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3742823/ https://www.ncbi.nlm.nih.gov/pubmed/23946789 http://dx.doi.org/10.3892/ol.2013.1337

Ejemplares similares

Global proteomic profiling in multistep hepatocarcinogenesis and identification of PARP1 as a novel molecular marker in hepatocellular carcinoma
por: Xu, Xiao, et al.
Publicado: (2016)

Characterization of genome-wide TFCP2 targets in hepatocellular carcinoma: implication of targets FN1 and TJP1 in metastasis
por: Xu, Xiao, et al.
Publicado: (2015)

LEPREL1 Expression in Human Hepatocellular Carcinoma and Its Suppressor Role on Cell Proliferation
por: Wang, Jianguo, et al.
Publicado: (2013)

TFCP2 Genetic Polymorphism Is Associated with Predisposition to and Transplant Prognosis of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2017)

Diagnostic Value of Preoperative Needle Biopsy for Tumor Grading Assessment in Hepatocellular Carcinoma
por: Wang, Lijun, et al.
Publicado: (2015)

Prediction of Early Recurrence of Hepatocellular Carcinoma in Patients with Cirrhosis Who Had Received Deceased Donor Liver Transplantation: A Multicenter Study
por: Al-Ameri, Abdulahad Abdulrab Mohammed, et al.
Publicado: (2019)

Annexin A2 as a biomarker for hepatocellular carcinoma in Egyptian patients
por: Shaker, Mohamed K, et al.
Publicado: (2017)

Deep learning for prediction of hepatocellular carcinoma recurrence after resection or liver transplantation: a discovery and validation study
por: Liu, Zhikun, et al.
Publicado: (2022)

miRNA profiles in livers with different mass deficits after partial hepatectomy and miR-106b~25 cluster accelerating hepatocyte proliferation in rats
por: Xu, Xiao, et al.
Publicado: (2016)

Clinical Significance of Annexin A4 as a Biomarker in the Early Diagnosis of Hepatocellular Carcinoma
por: Saad, Zienab M, et al.
Publicado: (2020)

Salinomycin-Loaded Small-Molecule Nanoprodrugs Enhance Anticancer Activity in Hepatocellular Carcinoma
por: Wang, Jianguo, et al.
Publicado: (2020)

The Stratifying Value of Hangzhou Criteria in Liver Transplantation for Hepatocellular Carcinoma
por: Chen, Jun, et al.
Publicado: (2014)

Annexin A2 promotion of hepatocellular carcinoma tumorigenesis via the immune microenvironment
por: Qiu, Li-Wei, et al.
Publicado: (2020)

The Combination Strategy of Transarterial Chemoembolization and Radiofrequency Ablation or Microwave Ablation against Hepatocellular Carcinoma
por: Xu, Zhentian, et al.
Publicado: (2019)

Genome-Wide Profiling of Alternative Splicing Signatures Associated with Prognosis and Immune Microenvironment of Hepatocellular Carcinoma
por: Liu, Zhikun, et al.
Publicado: (2021)

Phosphorylation of PED/PEA-15 at Ser116 and phosphorylation of p27 at Thr187 indicates a poor prognosis in hepatocellular carcinoma
por: Wu, Yifeng, et al.
Publicado: (2021)

Annexin A2 is a discriminative serological candidate in early hepatocellular carcinoma
por: Sun, Yulin, et al.
Publicado: (2013)

Indefinite antiviral therapy may be required after surgical resection for hepatocellular carcinoma complicating chronic hepatitis B
por: Wei, Qiang, et al.
Publicado: (2013)

Identification reproducible microbiota biomarkers for the diagnosis of cirrhosis and hepatocellular carcinoma
por: Zhang, Huarong, et al.
Publicado: (2023)

A Comparative Study of Serum Angiogenic Biomarkers in Cirrhosis and Hepatocellular Carcinoma
por: Pocino, Krizia, et al.
Publicado: (2021)

Combination of HSP90 and autophagy inhibitors promotes hepatocellular carcinoma apoptosis following incomplete thermal ablation
por: Chen, Fen, et al.
Publicado: (2020)

Cell Differentiation Trajectory in Liver Cirrhosis Predicts Hepatocellular Carcinoma Prognosis and Reveals Potential Biomarkers for Progression of Liver Cirrhosis to Hepatocellular Carcinoma
por: He, Zhaobin, et al.
Publicado: (2022)

The distinct responsiveness of cytokeratin 19-positive hepatocellular carcinoma to regorafenib
por: Zhuo, Jianyong, et al.
Publicado: (2021)

A Critical Role for ZDHHC2 in Metastasis and Recurrence in Human Hepatocellular Carcinoma
por: Peng, Chuanhui, et al.
Publicado: (2014)

Application of multi-modality MRI-based radiomics in the pre-treatment prediction of RPS6K expression in hepatocellular carcinoma
por: Yang, Fan, et al.
Publicado: (2023)

Liquid biopsy in hepatocellular carcinoma: circulating tumor cells and circulating tumor DNA
por: Ye, Qianwei, et al.
Publicado: (2019)

Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

AnnexinA7 promotes epithelial–mesenchymal transition by interacting with Sorcin and contributes to aggressiveness in hepatocellular carcinoma
por: Ling, Fei, et al.
Publicado: (2021)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
por: Ribeiro, Osmar Damasceno, et al.
Publicado: (2016)

Ras-related associated with diabetes gene acts as a suppressor and inhibits Warburg effect in hepatocellular carcinoma
por: Yan, Yingcai, et al.
Publicado: (2016)

UBAP2 negatively regulates the invasion of hepatocellular carcinoma cell by ubiquitinating and degradating Annexin A2
por: Bai, Dou-Sheng, et al.
Publicado: (2016)

The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill
por: Rui, Tao, et al.
Publicado: (2020)

Overexpression of CXCL2 inhibits cell proliferation and promotes apoptosis in hepatocellular carcinoma
por: Ding, Jun, et al.
Publicado: (2018)

Liver transplantation for hepatocellular carcinoma beyond the Milan criteria
por: Xu, Xiao, et al.
Publicado: (2016)

MicroRNA-452 promotes stem-like cells of hepatocellular carcinoma by inhibiting Sox7 involving Wnt/β-catenin signaling pathway
por: Zheng, Zhiyun, et al.
Publicado: (2016)

Investigation of potential molecular biomarkers and small molecule drugs for hepatocellular carcinoma transformed from cirrhosis
por: XIE, FENG, et al.
Publicado: (2016)

Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Hu, Xiaoyi, et al.
Publicado: (2020)

Polylactide-tethered prodrugs in polymeric nanoparticles as reliable nanomedicines for the efficient eradication of patient-derived hepatocellular carcinoma
por: Wang, Hangxiang, et al.
Publicado: (2018)

Annexin A8 can serve as potential prognostic biomarker and therapeutic target for ovarian cancer: based on the comprehensive analysis of Annexins
por: Gou, Rui, et al.
Publicado: (2019)

Efficacy and Safety of a Steroid-Free Immunosuppressive Regimen after Liver Transplantation for Hepatocellular Carcinoma
por: Wei, Qiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_oc102ica8bpnc0uanlnocm6m25